Cefixime

CEFVIB / JEMCEF

COMPOSITON
CEFIXIME50MG100 MG200 MG50 MG
SPECIFICATION
FORMTABLETTABLETTABLETPEDIATRIC
PACKING10X1010X1010X1030ML
PACKING TYPEALU ALUALU ALUALU ALU
MRP700800975.5 / 97544 | 43

ALSO AVAILABLE

DESCRIPTION

Cefixime, an antibiotic, is a third-generation cephalosporin like ceftriaxone and cefotaxime. Cefixime is highly stable in the presence of beta-lactamase enzymes. As a result, many organisms resistant to penicillins and some cephalosporins due to the presence of beta-lactamases, may be susceptible to cefixime. The antibacterial effect of cefixime results from inhibition of mucopeptide synthesis in the bacterial cell wall.

SIDE EFFECTS

Symptoms of overdose include blood in the urine, diarrhea, nausea, upper abdominal pain, and vomiting.

INDICATION

For use in the treatment of the following infections when caused by susceptible strains of the designated microorganisms: (1) uncomplicated urinary tract infections caused by Escherichia coli and Proteus mirabilis, (2) otitis media caused by Haemophilus influenzae (beta-lactamase positive and negative strains), Moraxella catarrhalis (most of which are beta-lactamase positive), and S. pyogenes, (3) pharyngitis and tonsillitis caused by S. pyogenes, (4) acute bronchitis and acute exacerbations of chronic bronchitis caused by Streptococcus pneumoniae and Haemophilus influenzae (beta-lactamase positive and negative strains), and (5) uncomplicated gonorrhea (cervical/urethral) caused by Neisseria gonorrhoeae (penicillinase- and non-penicillinase-producing strains).